Lucy Scientific Discovery Inc.
LSDIF
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 128.83% | 72.54% | 58.57% | 14.98% | -20.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 129.11% | 72.67% | 58.70% | 17.60% | -16.78% |
| Operating Income | -128.55% | -72.47% | -58.49% | -17.60% | 16.78% |
| Income Before Tax | -98.81% | -58.77% | -48.93% | -14.03% | 26.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -98.81% | -58.77% | -48.93% | -14.03% | 26.87% |
| Earnings from Discontinued Operations | -393.73% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.67% | -63.30% | -53.49% | -18.10% | 22.99% |
| EBIT | -128.55% | -72.47% | -58.49% | -17.60% | 16.78% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -41.50% | -15.87% | -5.07% | 23.97% | 50.02% |
| Normalized Basic EPS | -7.60% | 5.54% | 12.98% | 38.36% | 54.02% |
| EPS Diluted | -41.50% | -15.87% | -5.07% | 23.97% | 50.02% |
| Normalized Diluted EPS | -7.60% | 5.54% | 12.98% | 38.36% | 54.02% |
| Average Basic Shares Outstanding | 56.82% | 40.52% | 36.33% | 36.65% | 44.86% |
| Average Diluted Shares Outstanding | 56.82% | 40.52% | 36.33% | 36.65% | 44.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |